 |
Apogee Therapeutics
Last updated: July 09, 2024
CEO Michael Henderson
USA | Funding: $652M (+)
Website: http://www.apogeetherapeutics.com/
Apogee Therapeutics operates pipeline candidates designed to treat inflammatory and immunological disorders.
Website: http://www.apogeetherapeutics.com/
Apogee Therapeutics operates pipeline candidates designed to treat inflammatory and immunological disorders.
